SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

SILVEIRA, Marysabel Pinto Telis et al. Depressive symptoms in HIV-infected patients treated with highly active antiretroviral therapy. Rev. Bras. Psiquiatr. [online]. 2012, vol.34, n.2, pp.162-167. ISSN 1516-4446.

    1. Gibbie T, Mijch A, Ellen S, Hoy J, Hutchison C, Wright E, Chua P, Judd F. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up. Hiv Med. 2006;7:112-21. [ Links ]

    2. Judd F, Komiti A, Chua P, Mijch A, Hoy J, Grech P, Street A, Lloyd J, Williams. Nature of depression in patients with HIV/AIDS. Aust N Z J Psychiatry. 2005;39:826-32. [ Links ]

    3. Judd FK, Cockram AM, Komiti A, Mijch AM, Hoy J, Bell R. Depressive symptoms reduced in individuals with HIV/AIDS treated with highly active antiretroviral therapy: a longitudinal study. Aust N Z J Psychiatry. 2000;34:1015-21. [ Links ]

    4. Judd FK, Mijch AM. Depressive symptons in patients with HIV infection. Aust N Z J Psychiatry. 1996;30:104-09. [ Links ]

    5. Lyketsos CG, Hoover DR, Guccione M, Dew MA, Wesch J, Bing EG, Treisman GJ. Depressive symptoms over the course of HIV infection before AIDS. Soc Psychiatry Psychiatr Epidemiol. 1996a;31:212-19. [ Links ]

    6. Mello VA, Malbergier A. Depression in women infected with HIV. Rev Bras Psiquiatr. 2006;28(1):10-7. [ Links ]

    7. Williams JB, Rabkin JG, Remien RH, Gorman JM, Ehrhardt AA. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection II. Standardized clinical assessment of current and lifetime psychopathology. Arch Gen Psychiatry. 2001;48(2):124-30. [ Links ]

    8. Malbergier A. Aids e Psiquiatria - um Guia para os Profissionais de Saúde. Rio de Janeiro: Revinter; 2000. [ Links ]

    9. Leserman J, Petitto JM, Golden RN, Gaynes BN, Gu HB, Perkins DO, Silva SG, Folds JD, Evans DL. Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS. Am J Psychiatry. 2000;157:1221-8. [ Links ]

    10. Macintyre RC, Holzemer WL, Philippek M. Complementary and alternative medicine and HIV/AIDS. Part II: Select literature review. J Assoc Nurses AIDS Care. 1997;8:25-38. [ Links ]

    11. Fleischer NL, Fernald LC, Hubbard AE. Depressive Symptoms in Low-Income Women in Rural Mexico. Epidemiology. 2007;18:678-85. [ Links ]

    12. Cunha JA. Manual da versão em português das escalas de Beck. Casa do Psicólogo Livraria e Editora Ltda; 2001. [ Links ]

    13. Ministério da Saúde do Brasil. Recomendações para terapia anti-retroviral em adultos e adolescentes infectados pelo HIV-2006. Retrieved July 19, 2007, from: // [ Links ]

    14. Silveira MPT, Pinheiro CAT, Guttier MC, Pereira TVS, Moreira LB. Description of pharmaceutical care to assess their effectiveness on adherence to antirretroviral therapy - A randomized clinical trial. JMMS. 2010;1(5):171-177. Available online: [ Links ]

    15. Centers for Disease Control And Prevention Report of the NIH panel to define principles of therapy of HIV infection and guideliness for the use of antiretroviral agents in HIV-infected adults and adolescents TM. US. Department of Health and Human Services. Atlanta: 2000. [ Links ]

    16. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clinical Psychology Review: Baltimore 1998 In: Castanha AR, Coutinho MPL, Saldanha AAW, Ribeiro CG. Psychosocial repercussions of depression in the context of AIDS. Psicologia: ciência e profissão. 2006;26(1):70-81. [ Links ]

    17. Boly L, Cafaro V, Dyner T. Depressive symptoms predict increased incidence of nuropsychiatric side effects in patients treated with efavirenz. J Acquir Immune Defic Syndr. 2006;42(4):514-5. [ Links ]

    18. Clifford DB, Evans S, Yang YJ, Acosta EP, Goodkin K, Tashima K, et al . Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals. Ann Int Med. 2005;143(10):714-21. [ Links ]

    19. Lochet P, Peyrière H, Lotthé A, Mauboussim JM, Delmas B, Reynes J. Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz. HIV Med. 2003;4:62-6. [ Links ]

    20. Gutierrez F, Navarro A, Padilha S, Anton R, Masia M, Borrás J, Martín-Hidalgo A. Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring. Clin Infect Dis. 2005;41:1648-53. [ Links ]

    21. Fumaz CR, Muñoz-Moreno JA, Moltó J, Negredo E, Ferrer MJ, Sirera G, Pérez-Alvarez N, Gómez G, Burger D, Clotet B. Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence. J Acquir Immune Defic Syndr. 2005;38(5):560-5. [ Links ]

    22. Spire B, Carrieri P, Garzot MA, L'Henaff M, Obadia Y. Factors associated with efavirenz discontinuation in a large community-based sample of patients. AIDS Care. 2004;16(5):558-64. [ Links ]

    23. Starace S, Ammassari A, Trotta MP, De Longis P, Izzo C, Scalzini A d'Arminio Monforte A, Wu AW, Antinori A; AdICoNA Study Group; NeuroICoNA Study Group. Depression is a risk factor forsuboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002:31(Suppl.3):136-9. [ Links ]